Quantx Secures $85M Funding to Accelerate Oral Immunology Pipeline

Deal Summary

Quantx, a biotech firm focused on oral immunology, announced a $85 million financing round to advance its drug candidates. The new capital will fund preclinical and early clinical development, expanding its pipeline in the immunology space.